Faster Calculation of Scalp Area in Androgenetic Alopecia Before Platelet-Rich Plasma Therapy Using the Mobile Application ImageMeter

This study found that adding platelet-rich plasma with microneedling to conventional medical treatment significantly increased hair density and diameter in androgenetic alopecia patients compared to medical treatment alone.

In this study, intradermal injections of 0.5% minoxidil significantly improved hair growth and volume in women with female androgenetic alopecia compared to a placebo, with a good safety profile reported.

This study found that platelet rich plasma injections led to a 19.17% increase in hair density in males with androgenetic alopecia, although response did not correlate with age or duration of the condition.

This study found that PRP injections using the Eclipse system significantly improved hair density and caliber in women with androgenetic alopecia compared to saline placebo at 24 weeks.

In this study, researchers identified optimal hair follicle and follicular unit densities for successful hair transplantation in male patients with androgenetic alopecia in China.

This study found that platelet-rich plasma therapy showed varying levels of improvement in patients with androgenetic alopecia, though it is not yet considered evidence-based for this condition.

This pilot study found that platelet-rich plasma injections did not improve hair growth in men with androgenetic alopecia.

This study found that platelet-rich plasma may effectively increase hair follicle numbers in men with androgenetic alopecia, but changes in hair thickness plateaued after the second injection.

This study reports that monthly subcutaneous injections of concentrated growth factors improved hair appearance and density in patients with androgenetic alopecia, with no side effects observed in the follow-up period.

This study found that platelet-rich plasma injections improved hair density and diameter in women with androgenetic alopecia not responding to other treatments over 24 weeks, with no adverse events reported.

This study observed hair regrowth and increased density in four cases of androgenetic alopecia treated with a non-ablative erbium glass fractional laser and topical finasteride, with no significant side effects reported.

In this study, patients with mild to moderate androgenetic alopecia who received platelet-rich plasma injections with microneedling showed improvements in hair growth and thickness, as well as high satisfaction, over a three-month period compared to conventional therapy non-responders.

This study found that platelet rich plasma was more effective than minoxidil for treating androgenetic alopecia in males, with a good response observed in 76% of cases.

This retrospective study found that treatment with autologous plasma rich in growth factors increased hair density and improved hair follicle health in patients with androgenetic alopecia, with no reported adverse effects.

This study found that sequential treatment with platelet-rich plasma injection followed by mesotherapy may promote hair growth in various alopecia cases, showing clinical improvement in hair count and thickness.

This study found that a new topical agent, Scalp medⓇ, significantly improved hair count and thickness in men with androgenetic alopecia after 24 weeks of treatment.